Clinical efficacy evaluation of Erlotinib Combined with Concurrent Chemoradiotherapy in the treatment of locally advanced Pancreatic Cancer.

Liu, Ci; Yu, Haobin; Hou, Yue-Hong; Gao, Zhen-Lin; Zhang, Ya-Jing

Liu, Ci; Yu, Haobin; Hou, Yue-Hong; Gao, Zhen-Lin; Zhang, Ya-Jing.

Afiliação

Liu C; Ci Liu, Department of Internal Medicine, Beijing Water Resources Hospital, Beijing, 100036, China.
Yu H; Haobin Yu, Dept. of Cancer Nutrition & Metabolic Therapy, No.3 Ward of Oncology, Anhui Provincial Cancer Hospital, West Branch of the First Affiliated Hospital of USTC, Division of Life Sciences & Medicine, University of Science & Technology of China, Hefei 230001, Anhui P.R. China.
Hou YH; Yue-hong Hou, Department of Oncology, Shijiazhuang First Hospital, Shijiazhuang, Hebei, China.
Gao ZL; Zhen-lin Gao, Department of Oncology, Shijiazhuang First Hospital, Shijiazhuang, Hebei, China.
Zhang YJ; Ya-jing Zhang, Department of Oncology, Shijiazhuang First Hospital, Shijiazhuang, Hebei, China.

Pak J Med Sci ; 38(1): 118-122, 2022.

Article em En | MEDLINE | ID: mdl-35035411

Palavras-chave

Concurrent chemoradiotherapy; Erlotinib; Locally advanced pancreatic cancer; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pak J Med Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google